scorecardresearch
Add as a preferred source on Google
Saturday, November 1, 2025
TopicJohnson and Johnson

Topic: Johnson and Johnson

Rs 1 crore damages for ‘blatant infringement’: Johnson & Johnson’s big win in court against ORS copycats

New Delhi: The Delhi High Court has awarded damages of Rs 1.2 crore to multinational pharma company Johnson & Johnson in an infringement case...

Johnson & Johnson granted Rs 3.34 crore in damages by HC, what was the counterfeit products case

Offender was found to be a person, who ran a company by the name of Medserve. All seized counterfeit products can be destroyed by the healthcare giant, says HC.

Two doses of J&J’s vaccine slashes Omicron hospital stays in South Africa by up to 85%

The results are a welcome bit of news amid the explosive rise of Omicron cases and evidence that the strain can evade the protection that normally stems from vaccination.

Johnson & Johnson vaccine doesn’t provide antibody protection against Omicron, lab study finds

The J&J vaccine appears to provide some defense against Omicron, perhaps via other means such as stimulation of immune cells, according to a South African virologist.

US scientists suggest link between J&J vaccine and brain blood clots, but warn against panic

Researchers noted that the risk of blood clots should be considered in context of the vaccine’s efficacy, saying it is effective in offering protection from severe Covid-19.

Moderna, J&J boosters get US CDC’s backing, paving way for next shots

The CDC said eligible people may choose a different booster from the vaccine they originally received, granting more flexibility to patients and doctors.

US FDA clears Moderna, J&J booster shots, allows ‘mix and match’ of Covid vaccines

The Centers for Disease Control & Prevention will consult an expert panel later this week before finalising official recommendations for who should get boosters and when.

Johnson & Johnson seeks nod to conduct vaccine trails for 12-17 age group in India

Earlier in August, the US pharma giant Johnson & Johnson was given emergency use approval in India for its single-dose Covid-19 vaccine.

No clarity on India launch of single-dose J&J Covid jab as talks focus on indemnity hurdle

US pharmaceutical companies like Moderna, Pfizer and Johnson & Johnson have asked for indemnity against legal liability but the Government of India has not been inclined to give it.

J&J Covid vaccine gets emergency use nod in India. Here’s how the single-dose jab works

J&J became the fifth vaccine to get an emergency nod in the country, after Covishield, Covaxin, Sputnik V and Moderna.

On Camera

Game on in Gujarat — Ahmedabad is building India’s new sports economy

The massive success of the IPL is a watershed moment in Indian sports. It proved that sports could be an incredibly profitable commercial venture. The glamour, the glitz, and the spectacle of it didn’t go unnoticed.

Consumer Price Index gets up to date. Airfare, OTT plans, e-commerce prices in new basket—MoSPI secy

New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.

Joint production, closer ties, emerging tech: The foundation of new defence pact between India & US

The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.